Reference number : 276-2023-2024-Q3-00182, amendment number : , agreement type : C, recipient legal name : Nucliq Biologics Inc.|Nucliq Biologics Inc., recipient country : CA, recipient province : NL, recipient city : St. John's|St. John's, recipient postal code : A1A 1B3, program name english : REGI - Strategic Growth Initiative (SGI), program name french : CERI - Initiative de croissance stratégique (ICS), program purpose english : nan, program purpose french : nan, agreement title english : 225513, agreement title french : 225513, agreement number : 225513, agreement value : 50000.0, agreement start date : 2023-11-12, agreement end date : 2025-03-31, description english : Enhance technical research capabilities to support product development and company growth, description french : Améliorer recherche technique pour contribuer développ. produits et croissance entreprise, expected results english : nan, expected results french : nan, additional information english : The assistance type is Non-Repayable Contribution., additional information french : Le type d'aide est contribution non remboursable., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique